Detalhe da pesquisa
1.
Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
World J Surg Oncol
; 22(1): 10, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38178080
2.
Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer.
J Surg Oncol
; 126(4): 757-771, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661159
3.
Reply to Comment on "Risk factors for metachronous peritoneal carcinomatosis after radical resection for patients with nonmetastatic pT3-4 colon cancer".
J Surg Oncol
; 126(6): 1141-1144, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904144
4.
The safety and effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy in patients with pathological T3-4 locally advanced colon cancer.
Asian J Surg
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604861
5.
Prognostic Implications of Endoscopic Obstruction in Patients with Pathological Stage II Colon Cancers: a Single-Center Retrospective Cohort Study.
J Gastrointest Surg
; 27(1): 141-151, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352061
6.
The m7G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling.
Cancers (Basel)
; 15(22)2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38001714
7.
Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study.
Gastroenterol Rep (Oxf)
; 10: goac020, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35711715